Kemin Industries

Des Moines, IA, United States

Kemin Industries

Des Moines, IA, United States
SEARCH FILTERS
Time filter
Source Type

News Article | May 16, 2017
Site: www.prnewswire.com

"We are seeing increased demand for foods and supplements that can naturally help people increase their productivity throughout the day," said Kim Colletti, Global Cognition Product Manager at Kemin Human Health and Nutrition. "Neumentix has the potential to meet this growing demand, especially for busy professionals struggling to manage work, care for their families and maintain their health." Neumentix contains more than 50 phenolic constituents and is naturally-sourced from non-GMO lines of polyphenol-rich spearmint developed by Kemin. The complex botanical offers multiple uses for the global functional food and beverage market, which is expected to grow by $41 billion in five years.2 "The Neumentix GRAS status enables our customers to expand into the functional foods market and help further improve the lives of consumers by offering cognitive health benefits," said Anita Norian, President of Kemin Human Nutrition and Health. To learn more about Neumentix, visit www.neumentix.com. Kemin ( ) has been dedicated to using applied science to improve the quality of life for over half a century. As a global company touching 3.4 billion people every day with its products, Kemin is committed to improving the quality, safety and efficacy of food, feed and health-related products to feed a growing population and be a resource for others in need. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. The company provides product solutions and options to customers in more than 120 countries. A privately held, family-owned and operated company, Kemin has more than 2,000 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kemin-industries-spearmint-extract-achieves-self-affirmed-gras-status-300458127.html


News Article | July 12, 2017
Site: www.prnewswire.com

The CREST study examined the effect of adding (RS) meso-zeaxanthin to the standard National Eye Institute's Age-Related Eye Disease Study 2 (AREDS2) formula of 10 mg lutein and 2 mg zeaxanthin, plus low zinc. The study participants were randomly assigned to one of two AREDS2 (with low zinc) treatment groups: with 10 mg (RS) meso-zeaxanthin or no (RS) meso-zeaxanthin. After 24 months of follow-up in 98 participants with early AMD, there were no significant differences in measures of macular pigment or visual function between the treatments.1 "Supplement manufacturers should be aware that all 'zeaxanthin' is not the same. Some products are misrepresented as containing natural and dietary 'zeaxanthin' but contain a non-dietary, synthetic, zeaxanthin stereoisomer—3R, 3'S- zeaxanthin, or (RS) meso-zeaxanthin, which is one of three 'zeaxanthin' stereoisomers," said Richard Roberts, PhD, Kemin Principal Manager, Technical Services. "The findings are important because they build on the available evidence that suggests there is no additional benefit of adding (RS) meso-zeaxanthin to eye health supplements." (RS) Meso-zeaxanthin contained in dietary supplements is synthetically made from lutein using high heat and a strong alkaline environment.2 Research also indicates that (RS) meso-zeaxanthin present in the macula is made from dietary lutein and that supplemental (RS) meso-zeaxanthin may actually compete with lutein and zeaxanthin for absorption, keeping these important antioxidants from reaching the macula in the amounts needed for eye health.3,4,5 "Eye health supplement formulators should ask if all ingredients used in their product formulations are supported by science for safety and effectiveness," said Ceci Snyder, Global Vision Product Manager. FloraGLO® Lutein, which contains the same dietary forms of lutein and zeaxanthin as found in common foods such as spinach, kale and broccoli, is a quality lutein backed by science. FloraGLO is supported by over 80 human clinical trial publications and is the number one recommended lutein brand by eye doctors.6,7 The current study findings resulted from a European Research Council grant for the Central Retinal Enrichment Supplementation Trials (CREST). The research was conducted at the Macular Pigment Research Group, which is part of the Nutrition Research Centre Ireland at the School of Health Science, Waterford Institute of Technology in Waterford, Ireland. Study participants were diagnosed with early AMD. The findings continue to support the National Eye Institute's AREDS2 formulation with 10 mg of FloraGLO Lutein and 2 mg zeaxanthin as the standard eye health supplement formulation for age-related eye conditions. For more information on FloraGLO Lutein's safety and effectiveness, visit www.FloraGLO.com. Kemin (www.kemin.com) has been dedicated to using applied science to improve the quality of life for over half a century. As a global company touching 3.5 billion people every day with its products, Kemin is committed to improving the quality, safety and efficacy of food, feed and health-related products to feed a growing population and be a resource for others in need. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. The company provides product solutions and options to customers in more than 120 countries. A privately held, family-owned and operated company, Kemin has more than 2,000 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States.


News Article | September 19, 2017
Site: www.prnewswire.com

In this role, Bro will be responsible for growing the Crop Technologies portfolio while driving profitability and market share. Under her leadership and strategic guidance, the Crop Technologies initiative will continue to develop and offer innovative solutions that meet the needs of growers nationwide, while protecting specialty crops and ornamentals. "Crop Technologies is poised for success under Marsha's leadership," said Dr. Chris Nelson, President and CEO of Kemin. "Beyond her vision and business acumen, she has demonstrated success bringing new products to specialty market segments during her time at Kemin." Bro started working at Kemin in 2002 and has held finance, business intelligence and marketing roles across the company. In 2011, Bro was integral in launching the company's Personal Care business with a focus on developing and managing the marketing function. Most recently, she served as a Marketing Director on the corporate marketing team, developing worldwide strategic marketing and digital capabilities. Bro holds a Bachelor's degree in Finance and a Masters of Business Administration (MBA) from Drake University, Des Moines, Iowa. "We have an exciting opportunity to leverage our expertise as specialty crop growers and bridge innovative technologies across the vast market segments Kemin serves to create relevant, efficacious and profitable solutions unlike any others available in the horticulture market today," said Bro. Throughout 2017, Kemin strategically invested in growing the Crop Technologies team. In April, Brett Cranston was hired as a Sales Manager to work closely with customers to provide tailored solutions that enhance crop performance and profitability; and in June, Emily Fuerst was appointed Director of Research and Development to lead the development of new and innovative crop technology solutions. As a global nutritional ingredients company, Kemin manufactures more than 500 specialty ingredients for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. Many of the innovative ingredient solutions are sourced from specialty crops, developed in greenhouses and fields through the company's specialty crop improvement program. Click here to learn more about Crop Technologies. Kemin (www.kemin.com) has been dedicated to using applied science to improve the quality of life for over half a century. As a global company touching 3.8 billion people every day with its products, Kemin is committed to improving the quality, safety and efficacy of food, feed and health-related products to feed a growing population and be a resource for others in need. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. The company provides product solutions and options to customers in more than 120 countries. A privately held, family-owned and operated company, Kemin has more than 2,500 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States.


News Article | September 19, 2017
Site: www.prnewswire.com

"Few symposia provide in-depth discussion on the actual process of feed production, yet it's a critical topic for the industry. Feed represents about 75 percent of the cost of animal production, and feed manufacturing represents about 10 percent," said Dr. Chris Nelson, President and CEO of Kemin. "This conference equipped attendees with tools they can use to improve efficiencies in their operations." The panel provided educational, practical and business-focused insights that can be put in place to optimize the bottom line of feed production. Highlights from the series of expert presentations include: For more information on the feed processing solutions Kemin offers, click here. Kemin (www.kemin.com) has been dedicated to using applied science to improve the quality of life for over half a century. As a global company touching 3.8 billion people every day with its products, Kemin is committed to improving the quality, safety and efficacy of food, feed and health-related products to feed a growing population and be a resource for others in need. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. The company provides product solutions and options to customers in more than 120 countries. A privately held, family-owned and operated company, Kemin has more than 2,500 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States.


The new microalgae ingredients will be launched Wednesday, September 27 at the SupplySide West tradeshow in Las Vegas and will be marketed under the brand names, BetaVia Complete (whole cell Euglena gracilis) and BetaVia Pure (Paramylon/Linear beta-1,3-glucan). The pro-immunity ingredients will be offered as stand-alone ingredients and as part of Valensa's proprietary synergistic combinations. "We are enthusiastic about the launch of our BetaVia ingredients. Kemin's expansion into immune health highlights our continued initiative to become the supplier of choice for science-backed, high-quality dietary ingredients across platforms," said Anita Norian, President of Kemin Human Nutrition and Health. "Partnering with Valensa, a leader in the microalgae space, will help propel this ingredient forward in the U.S. market." The BetaVia product line offers a new, patented standard in immune support using Euglena gracilis microalgae. BetaVia ingredients are naturally-sourced, GMO- and gluten-free for functional applications. Both in vitro and animal studies show that algae-sourced BetaVia ingredients can prime key immune cells to strengthen the body's immune defenses. "Valensa and its affiliate Parry Nutraceuticals are market leaders in microalgae-based supplements with well-established ingredient brands in over 30 countries," said Umasudhan C.P., CEO of Valensa. "The relationship with Kemin allows us to introduce novel immunity supplement formulations made stronger by BetaVia, to our omni-channel customer base in the U.S. and internationally." This partnership creates a two-armed sales approach to the U.S. dietary supplement and functional foods and beverages markets. The Kemin sales team will service the functional food and beverage customers while Valensa's sales team will service customers producing dietary supplements. "We believe in a 'partner and grow' model that helps both companies leverage our mutual strengths to quickly penetrate the market and achieve sustainable growth. We take pride in partnering with Kemin, a company which has a strong reputation and credibility in the marketplace, and has shared values to help our customers create differentiated and effective dietary supplements that enhance health," continued Umasudhan. BetaVia ingredients will enhance Valensa's patent-protected and clinically-supported Immunum® dietary supplements, which are available in bulk powder blends. Valensa's patented BetaVia formulations for consumers include: Immunum Pro, containing BetaVia and proprietary spirulina extract for dual-action adaptive and innate immunity; Travel Armor™, containing BetaVia with fast-acting antioxidant protection for the frequent traveler; and Immunum Active, which delivers BetaVia with Zanthin® Natural Astaxanthin for recovery, stress support and year-round, balanced immune support. With this launch, Kemin adds to its catalog of ingredients for functional foods and beverages, building on its industry leadership in vision and cognition health. To learn more about BetaVia products and immune health, visit www.kemin.com/betavia. Valensa will be sampling BetaVia supplement formulations at booth O127 and Kemin will be at booth II159 during SupplySide West in Las Vegas. Kemin (www.kemin.com) has been dedicated to using applied science to improve the quality of life for over half a century. As a global company touching 3.8 billion people every day with its products, Kemin is committed to improving the quality, safety and efficacy of food, feed and health-related products to feed a growing population and be a resource for others in need. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. The company provides product solutions and options to customers in more than 120 countries. A privately held, family-owned and operated company, Kemin has more than 2,500 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States. Headquartered in Eustis, Florida, USA, Valensa International (www.valensa.com) designs condition-specific nutraceuticals, backed by clinical science and intellectual property protection for manufacture and distribution in the United States and select global markets. Founded in 1999, Valensa International is the proud owner of more than 60 U.S. and International Patents for Formulations and Manufacturing (Deep Extract® Supercritical CO2 and O2B® Peroxidation Blocker stabilization). Currently, Valensa International is spearheading research and development of microalgae-based products along with its flagship ingredients, Saw Palmetto and Astaxanthin, which are marketed under registered trademark brands USPlus® Saw Palmetto Extract and Zanthin® Natural Astaxanthin.  Additional formulations from Valensa include: FlexPro MD® and FlexPro ES® joint health formulations, Immunum™, EyePro MD®, Pur-Blue® SpiruZan® (Spirulina with Astaxanthin), Prostate 360®, Cran-Gyn® & FemCool® Women's Health Formulas, Tresalbio® Stabilized Chia Seed Oil, Verilla® Perilla Oil, Parry Organic Spirulina, Parry Organic Chlorella, and Parry Tomato Lycopene Complex.


Zion Research has published a new report titled “Antioxidants (Natural, and Synthetic) Market for Pharmaceuticals, Food & Beverages Sector, Feed Additives, Cosmetics Industry, and Other Applications: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2014 – 2020.” According to the report, global demand for antioxidants market was valued at around USD 2.25 billion in 2014 and is expected to reach USD 3.25 Billion in 2020, growing at a CAGR of approximately 5.5% between 2015 and 2020. An antioxidant is a molecule that inhibits the oxidation of other molecules. Oxidation is a chemical reaction involving the loss of electrons which can produce free radicals. Antioxidants naturally occur in large number of vegetables, fruits and foods. Beta-carotene, Lutein, Lycopene Selenium, Vitamin A, Vitamin C, and Vitamin E are important are some of the important sources of antioxidants. Theses antioxidants act as an inhibitor and restrict the formation of free radicals by chain oxidation reaction. Antioxidants are also called as reducing agents. Oxidation reactions are important for life; however, excessive free radicals can damage the cells in plants and animal. Antioxidants are widely used as in food & beverages and animal feed to prolong the shelf life of these products. Antioxidants are primarily used in meat and poultry products. Pharmaceuticals and cosmetics are other important outlets for antioxidants. Strong growth of theses application market globally is expected to boost demand for antioxidants across the world. However, high-dose supplements of antioxidants may be linked to health risks in some cases. For example, high doses of beta-carotene may increase the risk of lung cancer in smokers. High doses of vitamin E may increase risks of prostate cancer and one type of stroke. Antioxidant supplements may also interact with some medicines. This is expected to affect the growth of antioxidants industry to some extent. Antioxidants can be classified on the basis of product type such as natural and synthetic. The natural antioxidants includes rosemary extracts, vitamin C (including ascorbic acid), vitamin A (including carotenoids), and vitamin E (including tocopherols and tocotrienols). The synthetic antioxidants includes butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), and others. Synthetic antioxidants dominated the antioxidants market with over 60% shares to the total revenue generated in 2014. Demand for synthetic is expected to exhibit CAGR of over 5.5% through forecast period. Low prices have been resulted into growing popularity of synthetic antioxidants. On the other hand, growing demand for organic products is expected to boost demand for natural antioxidants. Antioxidants are used in various application areas such as, pharmaceuticals, food & beverages sector, feed additive, cosmetic industry, etc. Strong demand from these application industries contributed to the growth of global antioxidants market. Food & beverages was the largest application market antioxidants in 2014. Cosmetics industry is another important outlet for antioxidants. Moreover, rising demand for antioxidants as an animal feed additive is also expected to boost the demand for antioxidants in the years to come. Global antioxidants market was dominated by the Asia-Pacific and accounted for more than 30% shares of the total market in 2014. North America was the second highest regional market for antioxidants in 2014. The antioxidants market in Europe is expected to grow at a rapid pace in the years to come. Natural antioxidants market is expected to growth at robust CAGR in Europe and North America, owing to growing demand for organic products in the region. Some of the key players operating in global antioxidants market include Aland (Jiangsu) Nutraceutical Co., Ltd., Archer-Daniels-Midland Company, BASF S.E, Cargill Incorporated, DuPont, Kalsec Inc., Kemin Industries, Inc., Koninklijke DSM N.V., Naturex S.A., Nutreco N.V., and Vitablend Nederland B.V. The report segments the global antioxidants market as:


— Market Scenario Globally, the market for Carotenoids has been increasing due to changing life style and increase in disposable income. The key drivers for the market are increase in health awareness. Hence, Carotenoids Market is expected reach US XX Million at the end of the forecasted period and is expected to grow at CAGR of X.X% from 2016 to 2027. “Ask for your specific company profile and country level customization on reports.” Key Players • Allied Biotech • BASF • Kemin Industries • Koninklijke DSM • Alga technologies • D.D. Williamson • ExcelVite • Farbest Brands • FMC • Guangzhou Leader Bio-Technology • Lycored • PAT Vitamins • Valensa On The Basis of Form o Capsules o Powder o Tablets Taste the market data and market information presented through more than 70 market data tables and figures spread in 115 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Carotenoids Market Research Report - Forecast to 2027” Study Objectives of Global Carotenoids Market • To provide detailed analysis of the market structure along with forecast for the next 10 years of various segments and sub-segments of the Global Carotenoids Market • To provide insights about factors affecting the market growth • To Analyze the Global Carotenoids Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW) • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segment by Form, by application, and by type • To provide strategic profiling of the key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Carotenoids Market Regional Analysis of Global Carotenoids Market Europe and U.S. has dominated the market for Global Carotenoids Market with the largest market share, accounting for XX million and is expected to grow over XX million by 2027, Asia-Pacific and RoW are the growing market for Global Carotenoids Market and are expected to grow at CAGR of XX% respectively from 2016 to 2027. The TOC consists of the following chapters 1. Report prologue 2. Introduction 2.1 Definition 2.2 Scope of the study 2.2.1 Research objective 2.2.2 Assumptions 2.2.3 Limitations 2.3 Market structure 3. Research Methodology 3.1 Research process 3.2 Primary research 3.3 Secondary research 3.4 Market size estimation 3.5 Forecast model 4. Market Dynamics 4.1 Drivers 4.2 Restraints 4.3 Opportunities 5. Market factor analysis 5.1 Value chain analysis/Supply chain analysis 5.2 Porters five forces Continue………… Get Full Table of Content with List of Tables & Figure @ https://www.marketresearchfuture.com/request-toc/global-carotenoids-market-research-report-forecast-to-2027 The report for Global Carotenoids Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions. Related Report Global Green Coffee market segmented into product type, product applications and end users. Here, the product type of Green Coffee beans is segmented into Coffee Arabica and Coffee Robusta. The end user of this market is segmented into general public and patients of Blood Pressure and Heart. https://www.marketresearchfuture.com/articles/global-green-coffee-market-analysis-forecast-to-2017-2027 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. For more information, please visit https://www.marketresearchfuture.com/reports/global-carotenoids-market-research-report-forecast-to-2027


News Article | November 3, 2016
Site: www.newsmaker.com.au

The term Chamomile actually refers to a range of different daisy-like plants, which are a member of the Asteraceae family. The two most important species are German chamomile (Marticaria recutita) and Roman chamomile (Chamaemelum nobile). These two have an extensive industrial application. They are mainly used for their calming and anti-inflammatory properties, and each offer their own additional health benefits. Apart from these Chamomile has been used in teas as a mild, relaxing sleep aid, treatment for fevers, colds, stomach ailments, and as an anti-inflammatory, to name only a few therapeutic uses. The growing health consciousness among consumers is acting as major driver for the Chamomile market. Due the hectic & busy life schedule of industry professionals, they are not able to get a proper sleep. This leads to various sleeping disorders. This provides a door of opportunity for Chamomile, as it is extensively being used as a relaxing sleep aid. The global food & beverage industry is growing at a faster rate, especially the tea industry. Hence it gives wider opportunity for   market for chamomile extract market. There is growing demand for organic cosmetics in the recent trends. This has proved as a catalyst for the chamomile extract as it is an active ingredient used in many organically skin care cosmetics. However, there are many threats for the chamomile extract market in the form of conventional allopathic medicines and chemical based cosmetics. On the basis of end use, the chamomile extract market can be segmented into Tea, Allopathic medicines, Ayurvedic medicines, cosmetics. On the basis of application, the chamomile extract market  can be further segmented into Food and Beverages, Pharmaceuticals, Dietary Supplements, Personal Care/ Cosmetics and Others. Geographically, the acai berry market is segmented into seven regions which are ; North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific Excluding Japan (APEJ), and Middle East and Africa (MEA) and Japan. The Asia-Pacific region is the larger market in terms of consumption followed by Europe and North America. The region has potential for this product due to increasing demand from the end-use industries such as food beverage, pharmaceutical industry and others. In addition, growth in end-user industries is anticipated to surge the consumption of plant extracts. Some of the key players across the value chain dominating this market are Arjuna Natural Extracts Ltd , New Zealand Extracts Ltd, Kemin Industries, The Pharmaceutical Plant Company, Afriplex, Crown Iron Works Company, Changsha Vigorous-Tech Co., Ltd., Gehrliche, Ampak Company, Inc, Nutra Canada, Martin Bauer Group, Essenchem Plant Extract Co.,Ltd., Hunan Goldliloo Pharmaceutical Co., Ltd. These companies are developing market strategies such as mergers and acquisitions, Joint Venture, New product development and Expansion to increase their market share in Global Functional Beverages Market. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, end use and applications.


CHANDLER, Ariz., Feb. 28, 2017  /PRNewswire/ -- Memory Matters® from Bricker Labs, is one of three finalists selected for the prestigious NutrAward 2017 Finished Product Award. Winners will be announced March 9, 2017. Memory Matters® is formulated with Kemin's ingredient Neumentix™ Phe...


Memory Matters® from Bricker Labs, is one of three finalists selected for the prestigious NutrAward 2017 Finished Product Award. Winners will be announced March 9, 2017. Memory Matters® is formulated with Kemin's ingredient Neumentix™ Phenolic Complex K110-42, a proprietary, spearmint-based ingredient containing the unique Phenolic Complex. This ingredient is clinically tested, and shown to naturally support working memory, which helps facilitate multitasking, it can help one fall asleep faster, and it promotes more productive days. Age is a natural factor affecting memory, cognitive brain health, and mental sharpness. Working memory is the foundation for cognitive abilities such as attention, multitasking, and complex thinking. Research suggests working memory can naturally decline by approximately 10% per decade, starting in the early twenties. One clinical trial of individuals taking 900mg of Neumentix™ showed 15% improvement in the quality of working memory. Those taking Neumentix™ also showed 9% improvement in accuracy with spatial working memory, and reported falling asleep faster when compared to those taking a placebo. "It's exciting to be selected one of the top three finalists at Nutraward 2017, Natural Products Expo West with Memory Matters® with Neumentix™. Brain and memory health are key areas of concern in today's environment and Bricker Labs is proud to be on the leading edge in the development of quality nutritional supplements like Memory Matters®. We believe in science, innovation, and high-quality branded ingredients in the formulation of our nutritional products. The Bricker Labs' brand supports health and longevity for all." Trusted nationwide for more than 40 years, Bricker Labs serves the nutritional supplement industry as a manufacturer and distributor of its own brand of quality products, many of which are award- winning. Bricker Lab's serves consumers and retailers across the United States with supplements and vitamins of significant benefit and value in the health and wellness community. A full line of nutritional products including Memory Matters® with Neumentix is available online at Bricker Labs. Another source for Memory Matters® is available at AMAZON. Additionally, Bricker Labs products can be purchased at numerous retail stores in a variety of nutritional categories, such as Brain & Memory, Heart/Cardiovascular Health, Immune & Digestion Support, Weight Management, Sports Nutrition, and Energy. Memory Matters® with Neumentix™ is also available at The Vitamin Shoppe stores, Vitaminshoppe.com, and numerous health and natural food stores across the country. Kemin Industries, is a global company, ingredient manufacturer, and supplier of Neumentix™ Phenolic Complex K110-42. As a company, Kemin is dedicated to improving the quality of life through their quality products and services. This company touches half the population of the world every day, and delivers safe, high-quality ingredients backed by science and clinical research.

Loading Kemin Industries collaborators
Loading Kemin Industries collaborators